Cash Flow Statement
Growth Metrics

Xtant Medical Holdings (XTNT) Cash from Operations Growth (3y) (2013 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 4.78%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 9.30%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 20.35%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 22.35%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -48.14%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.50%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 50.11%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -14.75%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 15.83%
10 Xtant Medical Holdings 64.46 Mn 47.14 Mn 17.75 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 61.78%
Jun 30, 2025 339.80%
Mar 31, 2025 48.47%
Dec 31, 2024 16.28%
Sep 30, 2024 -22.88%
Jun 30, 2024 -62.14%
Mar 31, 2024 -63.90%
Dec 31, 2023 -44.21%
Sep 30, 2023 -277.98%
Jun 30, 2023 -140.07%
Mar 31, 2023 -7.86%
Dec 31, 2022 -218.22%
Sep 30, 2022 -16.78%
Jun 30, 2022 -68.14%
Mar 31, 2022 -59.39%
Dec 31, 2021 -40.33%
Sep 30, 2021 6.23%
Jun 30, 2021 175.12%
Mar 31, 2021 -96.07%
Dec 31, 2020 12.35%
Sep 30, 2020 45.27%
Jun 30, 2020 29.63%
Mar 31, 2020 -82.65%
Dec 31, 2019 71.94%
Sep 30, 2019 27.81%
Jun 30, 2019 27.09%
Mar 31, 2019 -21.87%
Dec 31, 2018 208.47%
Sep 30, 2018 38.96%
Jun 30, 2018 27.11%
Mar 31, 2018 28.33%
Dec 31, 2017 32.00%
Sep 30, 2017 30.66%
Jun 30, 2017 10.81%
Mar 31, 2017 30.05%
Dec 31, 2016 -136.55%
Sep 30, 2016 -28.50%
Jun 30, 2016 -90.32%
Mar 31, 2016 34.81%
Dec 31, 2015 71.00%
Sep 30, 2015 -18.76%
Jun 30, 2015 -1.52%
Mar 31, 2015 10.91%
Dec 31, 2014 -31.85%
Sep 30, 2014 13.03%
Jun 30, 2014 16.21%
Mar 31, 2014 -11.27%
Dec 31, 2013 28.37%
Sep 30, 2013 4.63%